A
Price
$125.02
Change
+$6.33 (+5.33%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
35.5B
94 days until earnings call
NVST
Price
$21.26
Change
+$0.02 (+0.09%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
3.53B
62 days until earnings call
Interact to see
Advertisement

A vs NVST

Header iconA vs NVST Comparison
Open Charts A vs NVSTBanner chart's image
Agilent Technologies
Price$125.02
Change+$6.33 (+5.33%)
Volume$25.25K
Capitalization35.5B
Envista Holdings
Price$21.26
Change+$0.02 (+0.09%)
Volume$9.88K
Capitalization3.53B
A vs NVST Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. NVST commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a StrongBuy and NVST is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (A: $124.96 vs. NVST: $21.24)
Brand notoriety: A and NVST are both not notable
A represents the Medical Specialties, while NVST is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: A: 240% vs. NVST: 128%
Market capitalization -- A: $35.5B vs. NVST: $3.53B
A [@Medical Specialties] is valued at $35.5B. NVST’s [@Pharmaceuticals: Other] market capitalization is $3.53B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.42B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 0 FA rating(s) are green whileNVST’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 0 green, 5 red.
  • NVST’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than NVST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 4 TA indicator(s) are bullish while NVST’s TA Score has 4 bullish TA indicator(s).

  • A’s TA Score: 4 bullish, 3 bearish.
  • NVST’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, A is a better buy in the short-term than NVST.

Price Growth

A (@Medical Specialties) experienced а +6.67% price change this week, while NVST (@Pharmaceuticals: Other) price change was +2.51% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.82%. For the same industry, the average monthly price growth was +6.47%, and the average quarterly price growth was +7.37%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.19%. For the same industry, the average monthly price growth was +5.15%, and the average quarterly price growth was +21.40%.

Reported Earning Dates

A is expected to report earnings on Dec 01, 2025.

NVST is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical Specialties (+0.82% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+4.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($35.5B) has a higher market cap than NVST($3.53B). NVST has higher P/E ratio than A: NVST (66.41) vs A (29.20). NVST YTD gains are higher at: 10.109 vs. A (-6.588). A has higher annual earnings (EBITDA): 1.76B vs. NVST (303M). A has more cash in the bank: 1.49B vs. NVST (1.11B). NVST has less debt than A: NVST (1.6B) vs A (3.5B). A has higher revenues than NVST: A (6.63B) vs NVST (2.55B).
ANVSTA / NVST
Capitalization35.5B3.53B1,005%
EBITDA1.76B303M581%
Gain YTD-6.58810.109-65%
P/E Ratio29.2066.4144%
Revenue6.63B2.55B260%
Total Cash1.49B1.11B134%
Total Debt3.5B1.6B219%
FUNDAMENTALS RATINGS
A vs NVST: Fundamental Ratings
A
NVST
OUTLOOK RATING
1..100
6766
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
74
Overvalued
PROFIT vs RISK RATING
1..100
73100
SMR RATING
1..100
4790
PRICE GROWTH RATING
1..100
6050
P/E GROWTH RATING
1..100
5147
SEASONALITY SCORE
1..100
750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (47) in the Biotechnology industry is in the same range as NVST (74) in the null industry. This means that A’s stock grew similarly to NVST’s over the last 12 months.

A's Profit vs Risk Rating (73) in the Biotechnology industry is in the same range as NVST (100) in the null industry. This means that A’s stock grew similarly to NVST’s over the last 12 months.

A's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for NVST (90) in the null industry. This means that A’s stock grew somewhat faster than NVST’s over the last 12 months.

NVST's Price Growth Rating (50) in the null industry is in the same range as A (60) in the Biotechnology industry. This means that NVST’s stock grew similarly to A’s over the last 12 months.

NVST's P/E Growth Rating (47) in the null industry is in the same range as A (51) in the Biotechnology industry. This means that NVST’s stock grew similarly to A’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANVST
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 16 days ago
62%
Bullish Trend 2 days ago
66%
Declines
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 14 days ago
70%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WDSCX18.49N/A
N/A
Allspring SMID Cap Growth Fund - Cl C
JVMCX27.92N/A
N/A
JHancock Disciplined Value Mid Cap C
NDVCX16.37N/A
N/A
MFS New Discovery Value C
PJDCX18.41N/A
N/A
PGIM Jennison Rising Dividend C
PRCFX28.77N/A
N/A
T. Rowe Price Cap Apprec And Inc

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been loosely correlated with BIO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then BIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
+0.47%
BIO - NVST
57%
Loosely correlated
-1.27%
A - NVST
55%
Loosely correlated
+0.33%
ALGN - NVST
54%
Loosely correlated
+0.14%
XRAY - NVST
53%
Loosely correlated
-0.07%
MTD - NVST
52%
Loosely correlated
+0.04%
More